glp-1 side effect lawsuit in kentucky Patients Are Suing Over Alleged Effects of Weight-Loss Drugs The 2 sides of Ozempic
Description
Obesity-associated leptin dysregulation also alters alveolar macrophage activity and leukotriene production, which may explain why obese asthmatics respond differently to corticosteroids but benefit from leukotriene modifiers
The primary risk is reduced effectiveness rather than acute harm
Many patients experiencing weight resistance also benefit from a deeper evaluation of metabolic and hormonal health
The ongoing development of new medications, including incretin co-agonists and tri-agonists, holds promise for treatments of even greater efficacy and individualized therapies in the coming years
